SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-05-27 11:42
Tx date 2024-05-17 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$1,905,192
+902,935 vol
$2.11 each 		902,935
Filed 2024-05-27 11:35
Tx date 2024-05-17 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$2,004,515
+902,935 vol
$2.22 each 		902,935
Filed 2023-06-28 12:35
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		90,000
Filed 2023-06-28 12:34
Tx date 2021-08-03 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2023-06-20 14:35
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Jane Gross
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		100,000
Filed 2023-06-20 14:24
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,206,000
+200,000 vol
$6.03 each 		600,000
Filed 2023-06-20 14:17
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		60,000
Filed 2023-06-20 14:04
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		115,000
Filed 2023-06-20 13:59
Tx date 2020-12-01 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		75,000
Filed 2023-06-20 13:47
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		115,000
Filed 2023-06-20 13:09
Tx date 2023-06-20 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$241,200
+40,000 vol
$6.03 each 		364,100
Filed 2022-12-28 15:45
Tx date 2022-12-28 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$128,357
+28,000 vol
$4.58 each 		169,856
Filed 2022-12-28 14:13
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$788.00
+400 vol
$1.97 each 		29,802
Filed 2022-12-28 14:12
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$2,300
+1,211 vol
$1.90 each 		29,402
Filed 2022-12-28 14:12
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$740.28
+372 vol
$1.99 each 		28,191
Filed 2022-12-28 14:11
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$1,027
+519 vol
$1.98 each 		27,819
Filed 2022-12-28 14:05
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$788.00
+400 vol
$1.97 each
Filed 2022-12-28 14:04
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$2,300
+1,211 vol
$1.90 each
Filed 2022-12-28 14:04
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$740.28
+372 vol
$1.99 each
Filed 2022-12-28 14:03
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$1,027
+519 vol
$1.98 each
Filed 2022-12-28 14:02
Tx date 2022-12-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$56.00
+28 vol
$2.00 each 		27,300
Filed 2022-12-20 16:12
Tx date 2022-12-20 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$117,713
+22,000 vol
$5.35 each 		141,856
Filed 2022-08-23 15:45
Tx date 2022-08-02 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+19,200 vol 		19,200
Filed 2022-08-23 15:41
Tx date 2016-11-01 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-23 11:49
Tx date 2022-08-02 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$853,084
+101,800 vol
$8.38 each 		324,100
Filed 2022-08-23 11:46
Tx date 2022-08-02 		$BCT
BriaCell Therapeutics Corp. 		DEL PRIORE, GIUSEPPE
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$83,800
+10,000 vol
$8.38 each 		160,000
Filed 2022-08-23 11:43
Tx date 2022-08-02 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,114
+20,300 vol
$8.38 each 		115,300
Filed 2022-08-23 11:36
Tx date 2022-08-02 		$BCT
BriaCell Therapeutics Corp. 		LOPEZ-LAGO, MIGUEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$83,800
+10,000 vol
$8.38 each 		25,000
Filed 2022-08-09 11:19
Tx date 2022-08-09 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-333 vol 		0
Filed 2022-07-22 14:43
Tx date 2020-12-01 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		575
Filed 2022-07-15 15:08
Tx date 2022-07-14 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$74,998
+27,272 vol
$2.75 each 		27,272
Filed 2022-07-10 12:45
Tx date 2022-07-10 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,667 vol 		400,000
Filed 2022-07-06 12:33
Tx date 2022-07-06 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-2,152 vol 		0
Filed 2022-07-06 12:27
Tx date 2022-07-06 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-100,000 vol 		0
Filed 2022-06-29 11:53
Tx date 2022-06-29 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-3,333 vol 		100,000
Filed 2022-06-03 15:12
Tx date 2022-05-26 		$BCT
BriaCell Therapeutics Corp. 		LOPEZ-LAGO, MIGUEL
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		15,000
Filed 2022-05-30 12:33
Tx date 2022-05-20 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		95,000
Filed 2022-03-08 15:19
Tx date 2022-02-14 		$BCT
BriaCell Therapeutics Corp. 		DEL PRIORE, GIUSEPPE
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		150,000
Filed 2022-02-17 20:25
Tx date 2022-02-17 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$432,822
+55,000 vol
$7.87 each 		1,640,000
Filed 2022-02-07 22:35
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Warrants
10 - Acquisition or disposition in the public market 		$67,250
+20,000 vol
$3.36 each 		20,000
Filed 2022-02-07 22:34
Tx date 2021-08-03 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-07 22:33
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$355,448
+55,000 vol
$6.46 each 		1,585,000
Filed 2022-02-07 22:32
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$67,250
+20,000 vol
$3.36 each
Filed 2022-02-07 22:32
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$355,448
+55,000 vol
$6.46 each
Filed 2022-02-07 21:51
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$67,250
+20,000 vol
$3.36 each
Filed 2022-02-07 21:51
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market 		$67,250
+20,000 vol
$3.36 each 		20,000
Filed 2022-02-07 21:50
Tx date 2021-08-03 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-07 21:49
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$355,448
+55,000 vol
$6.46 each
Filed 2022-02-07 21:49
Tx date 2022-02-02 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$355,448
+55,000 vol
$6.46 each 		55,000
Filed 2022-02-07 21:48
Tx date 2021-08-03 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-26 18:25
Tx date 2022-01-14 		$BCT
BriaCell Therapeutics Corp. 		BriCell Therapeutics Corp
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$423,500
+50,000 vol
$8.47 each 		60,000
Filed 2022-01-26 18:23
Tx date 2021-11-02 		$BCT
BriaCell Therapeutics Corp. 		BriCell Therapeutics Corp
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		10,000
Filed 2022-01-26 18:22
Tx date 2021-11-02 		$BCT
BriaCell Therapeutics Corp. 		BriCell Therapeutics Corp
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-26 18:18
Tx date 2021-11-02 		$BCT
BriaCell Therapeutics Corp. 		BriCell Therapeutics Corp
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-01-21 15:03
Tx date 2022-01-20 		$BCT
BriaCell Therapeutics Corp. 		Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$84,700
+10,000 vol
$8.47 each 		20,000
Filed 2022-01-21 14:56
Tx date 2022-01-20 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$423,500
+50,000 vol
$8.47 each 		75,000
Filed 2022-01-14 11:57
Tx date 2022-01-13 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		406,667
Filed 2022-01-13 17:11
Tx date 2022-01-13 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$423,500
+50,000 vol
$8.47 each 		75,000
Filed 2022-01-13 17:06
Tx date 2022-01-13 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$188,881
+22,300 vol
$8.47 each 		222,300
Filed 2022-01-13 16:59
Tx date 2022-01-13 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$423,500
+50,000 vol
$8.47 each 		75,000
Filed 2022-01-13 16:59
Tx date 2022-01-13 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$423,500
+50,000 vol
$8.47 each
Filed 2021-08-12 16:03
Tx date 2021-08-12 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
+70,000 vol 		103,333
Filed 2021-08-12 09:25
Tx date 2021-08-03 		$BCT
BriaCell Therapeutics Corp. 		Lustig, Marc
3 - 10% Security Holder of Issuer
Holder: L5 Capital Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,530,000
Filed 2021-07-08 14:31
Tx date 2021-07-08 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
+30,000 vol 		33,333
Filed 2021-06-22 17:04
Tx date 2019-10-10 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each 		2,857,142
Filed 2021-06-22 17:02
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-1,423,809 vol 		1,433,333
Filed 2021-06-22 17:02
Tx date 2019-10-10 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each
Filed 2021-06-22 16:59
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each 		1,428,571
Filed 2021-06-22 16:48
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-1,423,809 vol 		1,433,333
Filed 2021-06-22 16:47
Tx date 2019-10-10 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each
Filed 2021-06-22 16:47
Tx date 2019-10-10 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each 		2,857,142
Filed 2021-06-22 16:45
Tx date 2019-03-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Holder: Stratpath Management Inc (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-03 15:55
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-1,423,809 vol
Filed 2019-09-11 11:42
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each
Filed 2021-04-26 11:01
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,487
+5,715 vol
$3.06 each 		149,636
Filed 2021-04-26 11:00
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,672
+1,208 vol
$3.04 each 		143,921
Filed 2021-04-26 11:00
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,420
+2,000 vol
$3.21 each 		142,713
Filed 2021-04-26 10:58
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$117,600
+36,750 vol
$3.20 each 		140,713
Filed 2021-04-26 10:58
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,772
+2,750 vol
$3.19 each 		103,963
Filed 2021-04-26 10:57
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,856
+3,200 vol
$3.08 each 		101,213
Filed 2021-04-26 10:57
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,105
+5,500 vol
$3.11 each 		98,013
Filed 2021-04-26 10:56
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,005
+3,585 vol
$3.07 each 		92,513
Filed 2021-04-26 10:55
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,334
+425 vol
$3.14 each 		88,928
Filed 2021-04-26 10:55
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,050
+5,500 vol
$3.10 each 		88,503
Filed 2021-04-26 10:54
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$626.00
+200 vol
$3.13 each 		83,003
Filed 2021-04-26 10:54
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$12,243
+3,850 vol
$3.18 each 		82,803
Filed 2021-04-26 10:53
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$17,472
+5,600 vol
$3.12 each 		78,953
Filed 2021-04-26 10:53
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,195
+392 vol
$3.05 each 		73,353
Filed 2021-04-26 10:52
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,944
+1,600 vol
$3.09 each 		72,961
Filed 2021-04-26 10:51
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,133
+675 vol
$3.16 each 		71,361
Filed 2021-04-26 10:50
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,144
+3,200 vol
$3.17 each 		70,686
Filed 2021-04-26 10:50
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$315.00
+100 vol
$3.15 each 		67,486
Filed 2021-04-26 10:49
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,562
+500 vol
$3.13 each 		67,386
Filed 2021-04-26 10:48
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:49
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:46
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 18:49
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$259,835
+82,750 vol
$3.14 each 		149,636
Filed 2021-04-23 18:46
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$259,835
+82,750 vol
$3.14 each
Filed 2021-04-23 17:21
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,718
+2,000 vol
$3.86 each 		2,810
Filed 2021-04-23 17:17
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$318,000
+75,000 vol
$4.24 each 		75,667
Filed 2021-04-23 17:16
Tx date 2021-04-23 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-667 vol 		75,000
Filed 2021-03-31 14:00
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$106,000
+25,000 vol
$4.24 each 		25,000
Filed 2021-03-31 13:59
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-500,000 vol 		0
Filed 2021-03-30 17:58
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$636,000
+150,000 vol
$4.24 each 		156,667
Filed 2021-03-30 14:33
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$848,000
+200,000 vol
$4.24 each 		200,000
Filed 2021-03-30 14:32
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,500 vol 		0
Filed 2021-03-30 14:10
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$318,000
+75,000 vol
$4.24 each 		75,000
Filed 2021-03-30 14:09
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
-1,667 vol 		0
Filed 2021-03-30 13:58
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$106,000
+25,000 vol
$4.24 each 		25,000
Filed 2021-03-30 13:57
Tx date 2019-03-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-30 13:32
Tx date 2021-03-29 		$BCT
BriaCell Therapeutics Corp. 		Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$42,400
+10,000 vol
$4.24 each 		10,000
Filed 2021-03-30 13:30
Tx date 2019-03-07 		$BCT
BriaCell Therapeutics Corp. 		Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-14 15:47
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-20,052,392 vol 		66,886
Filed 2020-01-03 15:44
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-20,052,214 vol
Filed 2020-01-06 18:58
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-996,667 vol 		3,333
Filed 2020-01-06 18:56
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-1,993,333 vol 		6,667
Filed 2020-01-06 18:53
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-35,836,846 vol 		119,856
Filed 2020-01-05 13:00
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-99,667 vol 		333
Filed 2020-01-05 12:59
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-199,333 vol 		667
Filed 2020-01-05 12:56
Tx date 2020-01-02 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-242,047 vol 		810
Filed 2020-01-03 15:55
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-1,423,809 vol 		4,762
Filed 2020-01-03 15:53
Tx date 2019-10-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each
Filed 2020-01-03 15:44
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-20,052,214 vol 		67,064
Filed 2020-01-03 15:44
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-643,448 vol 		2,152
Filed 2020-01-03 15:42
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-747,500 vol 		2,500
Filed 2020-01-03 15:39
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
37 - Stock split or consolidation
-13,266,917 vol 		44,370
Filed 2020-01-03 15:38
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-69,767 vol 		233
Filed 2020-01-03 15:36
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-6,977 vol
Filed 2020-01-03 15:34
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
37 - Stock split or consolidation 		$-22,424,985
-498,333 vol
$45.00 each 		1,667
Filed 2020-01-03 14:19
Tx date 2020-01-03 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-632,000 vol 		750,000
Filed 2019-10-16 11:58
Tx date 2019-10-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each
Filed 2019-11-15 17:09
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		2,000,000
Filed 2019-11-15 17:07
Tx date 2019-11-15 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-1,000,000 vol 		1,000,000
Filed 2019-11-15 15:02
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		-1,000,000
Filed 2019-11-15 15:02
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 15:02
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 15:02
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 14:59
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-15 13:32
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		1,000,000
Filed 2019-11-15 13:32
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-09 16:58
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-09 16:58
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-14 16:30
Tx date 2019-11-14 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-2,806,041 vol 		645,600
Filed 2019-10-16 11:59
Tx date 2019-10-15 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$150,003
+2,142,900 vol
$0.07 each 		35,956,702
Filed 2019-10-16 11:58
Tx date 2019-10-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each 		2,857,142
Filed 2019-10-16 11:53
Tx date 2019-10-15 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$149,999
+2,142,857 vol
$0.07 each 		20,119,278
Filed 2019-09-12 10:28
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$220,801
+3,154,302 vol
$0.07 each 		33,813,802
Filed 2019-09-11 11:48
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$450,000
+6,428,572 vol
$0.07 each 		17,976,421
Filed 2019-09-11 11:48
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$7,000
+100,000 vol
$0.07 each 		11,547,849
Filed 2019-09-11 11:42
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$99,999
+1,428,571 vol
$0.07 each 		1,428,571
Filed 2019-09-11 11:41
Tx date 2019-03-15 		$BCT
BriaCell Therapeutics Corp. 		Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-09-10 15:27
Tx date 2019-09-09 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$9,999
+142,857 vol
$0.07 each 		242,857
Filed 2019-08-02 13:26
Tx date 2019-05-31 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+210,000 vol
Filed 2019-06-02 18:26
Tx date 2019-05-31 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+210,000 vol
Filed 2019-06-11 17:44
Tx date 2019-06-11 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+424,000 vol 		30,869,500
Filed 2019-06-10 16:35
Tx date 2019-06-10 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+576,000 vol 		30,445,500
Filed 2019-06-10 09:23
Tx date 2019-06-05 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+409,000 vol 		29,869,500
Filed 2019-06-05 09:03
Tx date 2019-06-04 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+286,000 vol 		29,460,500
Filed 2019-06-04 07:18
Tx date 2019-06-03 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+305,000 vol 		29,174,500
Filed 2019-06-02 18:26
Tx date 2019-05-31 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+210,000 vol 		28,869,500
Filed 2019-05-21 13:29
Tx date 2019-05-17 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+216,000 vol 		28,659,500
Filed 2019-05-16 17:04
Tx date 2019-05-16 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+332,000 vol 		28,443,500
Filed 2019-05-16 17:03
Tx date 2019-05-15 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+115,000 vol 		28,111,500
Filed 2019-05-14 16:37
Tx date 2019-05-14 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+20,000 vol 		27,996,500
Filed 2019-05-13 16:12
Tx date 2019-05-13 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,231,000 vol 		27,976,500
Filed 2019-05-09 17:58
Tx date 2019-05-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,000 vol 		26,745,500
Filed 2019-04-18 12:14
Tx date 2019-04-18 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+3,000,000 vol 		26,740,500
Filed 2019-04-17 19:46
Tx date 2019-04-17 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+200,000 vol 		23,740,500
Filed 2019-04-12 12:44
Tx date 2019-04-12 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$27,500
+250,000 vol
$0.11 each 		23,540,500
Filed 2019-03-25
Tx date 2019-03-25 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$500,000
+5,000,000 vol
$0.10 each 		23,290,500
Filed 2019-03-07
Tx date 2019-03-05 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+150,000 vol 		18,220,500
Filed 2019-03-07
Tx date 2019-03-06 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+70,000 vol 		18,290,500
Filed 2019-02-12
Tx date 2019-02-12 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,000,000 vol 		18,070,500
Filed 2019-02-09
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		16,070,500
Filed 2019-02-09
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		2,000,000
Filed 2019-02-09
Tx date 2019-02-09 		$BCT
BriaCell Therapeutics Corp. 		Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		2,200,000
Filed 2018-06-14
Tx date 2018-06-14 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$3,045
+21,000 vol
$0.145 each 		100,000
Filed 2018-06-14
Tx date 2018-06-13 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$11,455
+79,000 vol
$0.145 each 		79,000
Filed 2018-03-29
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
30 - Acquisition or disposition under a purchase/ownership plan 		$14,000
+100,000 vol
$0.14 each 		100,000
Filed 2018-03-29
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,000
+100,000 vol
$0.01 each 		100,000
Filed 2018-03-21
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$14,000
+100,000 vol
$0.14 each 		100,000
Filed 2018-03-21
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,000
+100,000 vol
$0.10 each 		172,391
Filed 2018-03-21
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2014-11-25 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$15,000
+150,000 vol
$0.10 each 		150,000
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$70,000
+500,000 vol
$0.14 each 		1,439,378
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,500
+37,500 vol
$0.12 each 		1,476,878
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,500
+62,500 vol
$0.12 each 		1,539,378
Filed 2018-03-20
Tx date 2016-04-29 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+175,000 vol
Filed 2018-03-20
Tx date 2016-04-29 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+175,000 vol 		175,000
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$50,000
+500,000 vol
$0.10 each 		675,000
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$64,560
+645,600 vol
$0.10 each 		3,451,641
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$90,384
+645,600 vol
$0.14 each 		11,447,849
Filed 2018-03-20
Tx date 2014-11-25 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20
Tx date 2018-03-19 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$21,000
+150,000 vol
$0.14 each 		150,000
Filed 2018-03-16
Tx date 2018-03-15 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-25,350
-195,000 vol
$0.13 each 		1,045,378
Filed 2018-03-16
Tx date 2018-03-16 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,600
-320,000 vol
$0.13 each
Filed 2018-03-16
Tx date 2018-03-16 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-13,780
-106,000 vol
$0.13 each 		939,378
Filed 2018-03-16
Tx date 2018-03-15 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-11,570
-89,000 vol
$0.13 each 		0
Filed 2018-03-16
Tx date 2018-03-16 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,600
-320,000 vol
$0.13 each
Filed 2018-03-08
Tx date 2016-05-09 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+500,000 vol
$0.255 each
Filed 2018-03-08
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+500,000 vol
$0.15 each 		500,000
Filed 2018-03-08
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-08
Tx date 2016-05-09 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+500,000 vol
$0.255 each
Filed 2018-03-08
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+500,000 vol
$0.15 each 		700,000
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$75,000
+500,000 vol
$0.15 each 		500,000
Filed 2018-03-02
Tx date 2018-02-28 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
-500,000 vol 		0
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$112,500
+750,000 vol
$0.15 each 		1,382,000
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		Lacher, Markus Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$15,000
+100,000 vol
$0.15 each 		600,000
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		Lacher, Markus Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2018-03-02
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,000
+500,000 vol
$0.15 each 		1,250,000
Filed 2018-03-01
Tx date 2018-03-01 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+200,000 vol
$0.15 each 		200,000
Filed 2018-03-01
Tx date 2018-01-15 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-51,000
-200,000 vol
$0.255 each 		0
Filed 2018-03-01
Tx date 2018-01-15 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$51,000
+200,000 vol
$0.255 each
Filed 2018-02-27
Tx date 2018-02-27 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-500,000 vol 		750,000
Filed 2018-02-27
Tx date 2018-02-27 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-500,000 vol 		200,000
Filed 2017-12-03
Tx date 2017-12-01 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$65.00
+500 vol
$0.13 each 		1,240,378
Filed 2017-12-03
Tx date 2017-12-01 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,250
+25,000 vol
$0.13 each 		1,239,878
Filed 2017-11-17
Tx date 2017-11-16 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$650.00
+5,000 vol
$0.13 each 		1,214,878
Filed 2017-11-15
Tx date 2017-11-15 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,675
+24,500 vol
$0.15 each 		1,209,878
Filed 2017-11-15
Tx date 2017-11-14 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,600
+10,000 vol
$0.16 each 		1,185,378
Filed 2017-10-05
Tx date 2017-10-04 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,350
+10,000 vol
$0.135 each 		1,175,378
Filed 2017-09-17
Tx date 2017-08-21 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$162,125
+1,013,283 vol
$0.16 each 		10,802,249
Filed 2017-09-17
Tx date 2017-08-21 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$198,125
+1,238,283 vol
$0.16 each
Filed 2017-09-01
Tx date 2017-09-01 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,250
+50,000 vol
$0.165 each 		1,165,378
Filed 2017-09-01
Tx date 2017-09-01 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,200
+20,000 vol
$0.16 each 		1,115,378
Filed 2017-08-28
Tx date 2017-08-28 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,000
+50,000 vol
$0.16 each 		1,095,378
Filed 2017-08-22
Tx date 2017-08-21 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$198,125
+1,238,283 vol
$0.16 each 		11,027,249
Filed 2017-08-22
Tx date 2017-08-21 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition 		$11,582
+72,391 vol
$0.16 each 		72,391
Filed 2017-08-22
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-17
Tx date 2017-08-15 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-32,000
-200,000 vol
$0.16 each 		1,045,378
Filed 2017-08-10
Tx date 2017-08-09 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$649,350
+4,058,441 vol
$0.16 each 		9,788,966
Filed 2017-08-10
Tx date 2017-08-10 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$320.00
+2,000 vol
$0.16 each 		1,245,378
Filed 2017-08-10
Tx date 2017-08-10 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$480.00
+3,000 vol
$0.16 each 		1,243,378
Filed 2017-08-08
Tx date 2017-08-04 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,600
+10,000 vol
$0.16 each 		1,240,378
Filed 2017-08-03
Tx date 2017-08-03 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$320.00
+2,000 vol
$0.16 each 		1,230,378
Filed 2017-08-03
Tx date 2017-08-02 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$80.00
+500 vol
$0.16 each 		1,228,378
Filed 2017-07-28
Tx date 2017-07-27 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$247.50
+1,500 vol
$0.165 each 		1,227,878
Filed 2017-07-18
Tx date 2017-07-17 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$247.50
+1,500 vol
$0.165 each 		1,226,378
Filed 2017-07-17
Tx date 2017-07-17 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$577.50
+3,500 vol
$0.165 each 		1,224,878
Filed 2017-05-01
Tx date 2017-04-27 		$BCT
BriaCell Therapeutics Corp. 		Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$22,050
+315,000 vol
$0.07 each 		1,315,000
Filed 2017-05-01
Tx date 2017-04-27 		$BCT
BriaCell Therapeutics Corp. 		Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$36,000
+720,000 vol
$0.05 each 		768,000
Filed 2017-03-29
Tx date 2017-03-28 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$982,114
+2,806,041 vol
$0.35 each 		2,806,041
Filed 2017-03-29
Tx date 2017-03-28 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$1,964,229
+5,612,083 vol
$0.35 each
Filed 2017-03-29
Tx date 2017-03-28 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$1,964,229
+5,612,083 vol
$0.35 each
Filed 2017-03-28
Tx date 2017-03-28 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
53 - Grant of warrants 		$1,964,229
+5,612,083 vol
$0.35 each 		5,612,083
Filed 2017-03-28
Tx date 2016-11-01 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-03-28
Tx date 2017-03-28 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$1,346,899
+5,612,083 vol
$0.24 each 		5,730,525
Filed 2017-03-28
Tx date 2017-01-18 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,307
+57,292 vol
$0.145 each 		57,292
Filed 2017-03-28
Tx date 2017-01-18 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,957
+27,292 vol
$0.145 each
Filed 2017-03-15
Tx date 2017-03-15 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,500
+25,000 vol
$0.22 each 		1,221,378
Filed 2017-03-09
Tx date 2017-03-09 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,380
+6,000 vol
$0.23 each 		1,196,378
Filed 2017-03-01
Tx date 2017-02-23 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,000
+50,000 vol
$0.14 each 		88,442
Filed 2017-03-01
Tx date 2017-01-20 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,672
+11,150 vol
$0.15 each 		38,442
Filed 2017-03-01
Tx date 2017-01-18 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,957
+27,292 vol
$0.145 each 		27,292
Filed 2017-03-01
Tx date 2016-11-01 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-28
Tx date 2017-02-28 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,945
-29,000 vol
$0.205 each 		1,190,378
Filed 2017-02-28
Tx date 2017-02-28 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,515
-21,000 vol
$0.215 each 		1,219,378
Filed 2017-02-17
Tx date 2017-02-17 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,250
+25,000 vol
$0.21 each 		1,240,378
Filed 2017-02-10
Tx date 2017-02-09 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,250
+25,000 vol
$0.17 each 		1,215,378
Filed 2017-02-07
Tx date 2017-02-07 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$680.00
+4,000 vol
$0.17 each 		1,190,378
Filed 2017-02-07
Tx date 2017-02-07 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,230
+19,000 vol
$0.17 each 		1,186,378
Filed 2017-02-07
Tx date 2017-02-07 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$340.00
+2,000 vol
$0.17 each 		1,167,378
Filed 2017-01-11
Tx date 2017-01-10 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$760.00
+4,000 vol
$0.19 each 		1,165,378
Filed 2016-11-22
Tx date 2016-11-21 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$320.00
+2,000 vol
$0.16 each 		89,000
Filed 2016-11-22
Tx date 2016-11-18 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$797.50
+5,500 vol
$0.145 each 		87,000
Filed 2016-11-22
Tx date 2016-11-18 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$7,974
+55,000 vol
$0.145 each
Filed 2016-11-22
Tx date 2016-11-18 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,560
+28,500 vol
$0.16 each 		81,500
Filed 2016-11-22
Tx date 2016-11-18 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Holder: KJN Management Ltd (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$150.00
+1,000 vol
$0.15 each 		53,000
Filed 2016-11-03
Tx date 2016-11-01 		$BCT
BriaCell Therapeutics Corp. 		WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		632,000
Filed 2016-10-17
Tx date 2016-10-17 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-104,300
-521,500 vol
$0.20 each 		13,311,287
Filed 2016-10-17
Tx date 2016-10-17 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,842.50
-28,500 vol
$0.205 each 		13,832,787
Filed 2016-10-17
Tx date 2016-10-17 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-210.00
-1,000 vol
$0.21 each 		13,861,287
Filed 2016-10-17
Tx date 2016-10-13 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,947.50
-9,500 vol
$0.205 each 		13,862,287
Filed 2016-09-27
Tx date 2016-05-09 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+500,000 vol
$0.255 each 		500,000
Filed 2016-08-10
Tx date 2016-08-10 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,925
+13,000 vol
$0.225 each 		1,161,378
Filed 2016-08-05
Tx date 2016-08-05 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,075
+5,000 vol
$0.215 each 		1,148,378
Filed 2016-08-05
Tx date 2016-08-05 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,505
+7,000 vol
$0.215 each 		1,143,378
Filed 2016-06-20
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-05-10 		$BCT
BriaCell Therapeutics Corp. 		Schmieg, Martin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-05-27 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$51,000
+200,000 vol
$0.255 each 		200,000
Filed 2016-04-29
Tx date 2016-04-29 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+175,000 vol 		175,000
Filed 2016-04-29
Tx date 2006-07-27 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-29
Tx date 2016-04-29 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$140,000
+700,000 vol
$0.20 each 		1,136,378
Filed 2016-04-25
Tx date 2016-04-22 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-140,000
-700,000 vol
$0.20 each 		436,378
Filed 2016-03-29
Tx date 2016-02-01 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-02-01 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-02-01 		$BCT
BriaCell Therapeutics Corp. 		Levin, Gadi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-27
Tx date 2016-01-25 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$17,500
+70,000 vol
$0.25 each 		70,000
Filed 2016-01-27
Tx date 2014-11-25 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Wiseman Cancer Research Foundation (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-27
Tx date 2016-01-25 		$BCT
BriaCell Therapeutics Corp. 		WISEMAN, CHARLES LOUIS
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-17,500
-70,000 vol
$0.25 each 		13,871,787
Filed 2015-12-21
Tx date 2015-12-10 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$819.50
+5,000 vol
$0.1639 each 		30,000
Filed 2015-12-07
Tx date 2015-12-07 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$861.50
+5,000 vol
$0.1723 each 		25,000
Filed 2015-12-07
Tx date 2015-12-07 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$862.50
+5,000 vol
$0.1725 each 		20,000
Filed 2015-12-07
Tx date 2015-12-07 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$841.50
+5,000 vol
$0.1683 each 		15,000
Filed 2015-12-07
Tx date 2015-12-04 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$783.00
+4,500 vol
$0.174 each 		10,000
Filed 2015-12-07
Tx date 2015-12-04 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$751.05
+4,500 vol
$0.1669 each 		5,500
Filed 2015-12-07
Tx date 2015-12-04 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$83.30
+500 vol
$0.1666 each 		1,000
Filed 2015-12-07
Tx date 2015-12-04 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$81.60
+500 vol
$0.1632 each 		500
Filed 2015-12-07
Tx date 2015-06-01 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-06
Tx date 2015-11-04 		$BCT
BriaCell Therapeutics Corp. 		WRIGHT, MATTHEW GEORGE
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$6,375
+25,000 vol
$0.255 each 		100,000
Filed 2015-11-05
Tx date 2015-11-04 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$255,000
+1,000,000 vol
$0.255 each 		1,000,000
Filed 2015-11-05
Tx date 2015-06-01 		$BCT
BriaCell Therapeutics Corp. 		Wagner, Joseph Paul
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-05
Tx date 2015-11-04 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$51,000
+200,000 vol
$0.255 each 		700,000
Filed 2015-11-05
Tx date 2015-11-04 		$BCT
BriaCell Therapeutics Corp. 		Maresky, Isaac Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$127,500
+500,000 vol
$0.255 each 		1,000,000
Filed 2015-11-05
Tx date 2015-11-04 		$BCT
BriaCell Therapeutics Corp. 		Babaei, Saeid
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$191,250
+750,000 vol
$0.255 each 		1,250,000
Filed 2015-06-30
Tx date 2015-06-30 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,000
+25,000 vol
$0.24 each 		1,136,378
Filed 2015-06-11
Tx date 2015-06-10 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,500
+25,000 vol
$0.26 each 		1,111,378
Filed 2015-05-08
Tx date 2015-05-06 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33,000
+100,000 vol
$0.33 each 		1,086,378
Filed 2015-05-05
Tx date 2015-05-04 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-231.82
-692 vol
$0.335 each 		986,378
Filed 2015-05-05
Tx date 2015-05-04 		$BCT
BriaCell Therapeutics Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-64,600
-190,000 vol
$0.34 each 		987,070
Filed 2014-01-24
Tx date 2014-01-24 		$BCT
Ansell Capital Corp. 		SHARAN, RAHOUL
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,430
+98,000 vol
$0.035 each 		3,701,166